New Zealand Formulary
Menu Close Menu

Fewer cancers.
Better survival.
Equity for all.

Systemic Anti-Cancer Therapy Regimen Library

Home > Colorectal

Colorectal Regimens



Anal Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
CRC ACA Advanced - cARBOplatin and PACLItaxel
264471000210100
1.0.0
16/06/2023
CRC ACA - cISplatin and fluorouracil chemoradiation
265271000210102
2.0.0
08/05/2026
CRC ACA Metastatic - nivolumab Q2W [flat dosing]
496861000210103
1.0.0
08/02/2025
CRC ACA Metastatic - nivolumab Q4W [flat dosing]
496851000210101
1.0.0
08/02/2025
CRC ACA Metastatic - pembrolizumab Q3W [flat dosing]
496841000210104
1.0.0
08/02/2025
CRC ACA Metastatic - pembrolizumab Q6W [flat dosing]
496831000210107
1.0.0
08/02/2025
CRC ACA - mitomycin and capecitabine chemoradiation
265261000210108
1.0.0
22/08/2023
CRC ACA - mitomycin and fluorouracil chemoradiation
265251000210105
1.0.0
22/08/2023

Metastatic Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
CRC ACA Metastatic - nivolumab Q2W [flat dosing]
496861000210103
1.0.0
08/02/2025
CRC ACA Metastatic - nivolumab Q4W [flat dosing]
496851000210101
1.0.0
08/02/2025
CRC ACA Metastatic - pembrolizumab Q3W [flat dosing]
496841000210104
1.0.0
08/02/2025
CRC ACA Metastatic - pembrolizumab Q6W [flat dosing]
496831000210107
1.0.0
08/02/2025
CRC Metastatic - capecitabine 1000
52071000210102
2.0.0
13/08/2023
CRC Metastatic - capecitabine 1250
52061000210108
2.0.0
13/08/2023
CRC Metastatic - capecitabine and beVACizumab
52051000210105
2.0.0
13/08/2023
CRC Metastatic - capecitabine and mitomycin
52041000210107
2.0.0
13/08/2023
CRC Metastatic - CAPOX [capecitabine and oxaliplatin]
52081000210100
2.0.0
18/11/2024
CRC Metastatic - CAPOX [capecitabine and oxaliplatin] and beVACizumab
52031000210104
2.0.0
18/11/2024
CRC Metastatic - CETUximab [Q2W] and daBRAFEnib
311891000210106
2.0.0
13/03/2025
CRC Metastatic - CETUximab [Q2W] and encorafenib
311901000210107
2.0.0
13/03/2025
CRC Metastatic - CETUximab and irinotecan [Q2W]
52001000210109
4.0.0
13/03/2025
CRC Metastatic - CETUximab [Q2W] and sotorasib
506831000210103
1.0.0
30/03/2026
CRC Metastatic - CETUximab Q2W
311961000210106
2.0.0
13/03/2025
CRC Metastatic - FLOX [oxaliplatin, foliNIc acid and fluorouracil]
51911000210103
2.0.0
18/11/2024
CRC Metastatic - fruquintinib
496821000210105
1.0.0
08/02/2025
CRC Metastatic - irinotecan [Q3W] dose reduced
311971000210100
1.0.0
03/03/2024
CRC Metastatic - irinotecan Q3W
51991000210106
2.0.0
13/08/2023
CRC Metastatic - IrOX [oxaliplatin and irinotecan]
51981000210109
4.0.0
01/04/2026
CRC Metastatic - mCAPIRI [irinotecan and capecitabine]
51971000210107
2.0.0
18/11/2024
CRC Metastatic - mDe Gramont [foliNIc acid and fluorouracil] [high dose foliNIc acid]
52591000210105
2.0.0
18/11/2024
CRC Metastatic - mDe Gramont [foliNIc acid and fluorouracil] [low dose foliNIc acid]
52611000210103
2.0.0
18/11/2024
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil [bolus and infusion]] [high dose foliNIc acid]
51961000210101
2.0.0
23/04/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil [bolus and infusion]] [low dose foliNIc acid]
51951000210104
2.0.0
23/04/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid]
588331000210107
1.0.0
01/07/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [low dose foliNIc acid]
588291000210101
1.0.0
01/07/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil [bolus and infusion]] and beVACizumab [high dose foliNIc acid]
51941000210102
2.0.0
23/04/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil [bolus and infusion]] and beVACizumab [low dose foliNIc acid]
51931000210105
2.0.0
23/04/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid] and beVACizumab
588321000210105
1.0.0
01/07/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [low dose foliNIc acid] and beVACizumab
588281000210103
1.0.0
01/07/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil [bolus and infusion]] and CETUximab [Q2W] [high dose foliNIc acid]
51921000210108
4.0.0
23/04/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil [bolus and infusion]] and CETUximab [Q2W] [low dose foliNIc acid]
52091000210103
4.0.0
23/04/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid] and CETUximab [Q2W]
588311000210100
1.0.0
01/07/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [low dose foliNIc acid] and CETUximab [Q2W]
588341000210104
1.0.0
01/07/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid], CETUximab [Q2W] and encorafenib
588301000210102
1.0.0
01/07/2026
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [low dose foliNIc acid], CETUximab [Q2W] and encorafenib
588271000210100
1.0.0
01/07/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil [bolus and infusion]] [high dose foliNIc acid]
52101000210105
2.0.0
23/04/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil [bolus and infusion]] [low dose foliNIc acid]
52111000210107
2.0.0
23/04/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
588251000210108
1.0.0
01/07/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
588211000210109
1.0.0
01/07/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil [bolus and infusion]] and beVACizumab [high dose foliNIc acid]
52121000210102
2.0.0
23/04/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil [bolus and infusion]] and beVACizumab [low dose foliNIc acid]
52131000210100
2.0.0
23/04/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid] and beVACizumab
588241000210105
1.0.0
01/07/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid] and beVACizumab
588201000210107
1.0.0
01/07/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil [bolus and infusion]] and CETUximab [Q2W] [high dose foliNIc acid]
52141000210108
4.0.0
23/04/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil [bolus and infusion]] and CETUximab [Q2W] [low dose foliNIc acid]
52151000210106
4.0.0
23/04/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid] and CETUximab [Q2W]
588231000210102
1.0.0
01/07/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid] and CETUximab [Q2W]
588261000210106
1.0.0
01/07/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid], CETUximab [Q2W] and encorafenib
588221000210104
1.0.0
01/07/2026
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid], CETUximab [Q2W] and encorafenib
588191000210105
1.0.0
01/07/2026
CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
52271000210109
4.0.0
01/04/2026
CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
52261000210103
4.0.0
01/04/2026
CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] with beVACizumab [high dose foliNIc acid]
52301000210107
4.0.0
01/04/2026
CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] with beVACizumab [low dose foliNIc acid]
52251000210101
4.0.0
01/04/2026
CRC Metastatic - mQUASAR [foliNIc acid and fluorouracil]
51881000210103
2.0.0
18/11/2024
CRC Metastatic - mRoswell Park [foliNIc acid and fluorouracil] [high dose foliNIc acid]
52241000210104
2.0.0
18/11/2024
CRC Metastatic - mRoswell Park [foliNIc acid and fluorouracil] [low dose foliNIc acid]
52481000210107
2.0.0
18/11/2024
CRC Metastatic - nivolumab 240 mg and ipilimumab 1 mg/kg Q3W, followed by nivolumab 480 mg Q4W
588181000210108
1.0.0
01/07/2026
CRC Metastatic - pembrolizumab 200 mg and ipilimumab 1 mg/kg Q3W, followed by pembrolizumab 400 mg Q6W
588161000210100
1.0.0
01/07/2026
CRC Metastatic - pembrolizumab Q3W [flat dosing]
311911000210109
1.0.0
29/02/2024
CRC Metastatic - pembrolizumab Q6W [flat dosing]
311931000210102
1.0.0
29/02/2024
CRC Metastatic - raltitrexed
52471000210105
2.0.0
13/08/2023
CRC Metastatic - raltitrexed and oxaliplatin
52501000210104
2.0.0
13/08/2023
CRC Metastatic - regorafenib 120
496811000210100
1.0.0
08/02/2025
CRC Metastatic - trifluridine/tipiracil
311941000210105
1.0.0
29/02/2024
CRC Metastatic - trifluridine/tipiracil and beVACizumab
311951000210108
1.0.0
29/02/2024
CRC REC Metastatic - capecitabine chemoradiation [5 day dosing]
52631000210105
3.0.0
13/08/2023
CRC REC Metastatic - capecitabine chemoradiation [continuous dosing]
52791000210100
3.0.0
13/08/2023
CRC REC Metastatic - fluorouracil chemoradiation
52601000210100
3.0.0
13/08/2023

Superseded Regimens

Name Sort
Id Sort
Version Sort
Date Sort
CRC Metastatic - CETUximab [Q1W]
52021000210101
3.0.2
29/03/2026
CRC Metastatic - CETUximab [Q1W] and encorafenib
264451000210108
1.0.2
29/03/2026
CRC Metastatic - CETUximab [Q1W] and irinotecan [Q2W]
52011000210106
2.0.2
29/03/2026
CRC Metastatic - CETUximab [Q1W], biNIMEtinib and encorafenib
264461000210106
1.0.2
29/03/2026
CRC Metastatic - CETUximab [Q1W], daBRAFEnib and tRAMEtinib
265201000210109
1.0.2
29/03/2026
CRC Metastatic - mFOLFIRI and CETUximab [Q1W] [high dose foliNIc acid]
52291000210108
2.0.2
29/03/2026
CRC Metastatic - mFOLFIRI and CETUximab [Q1W] [low dose foliNIc acid]
52281000210106
2.0.2
29/03/2026
CRC Metastatic - regorafenib
52161000210109
4.0.2
29/03/2026

NON-Metastatic Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
CRC ACA Advanced - cARBOplatin and PACLItaxel
264471000210100
1.0.0
16/06/2023
CRC Adjuvant - capecitabine
52171000210103
2.0.0
07/02/2024
CRC Adjuvant - CAPOX [capecitabine and oxaliplatin]
52181000210101
2.0.0
18/11/2024
CRC Adjuvant - MAYO [foliNIc acid and fluorouracil]
51891000210101
2.0.0
18/11/2024
CRC Adjuvant - mDe Gramont [foliNIc acid and fluorouracil] [high dose foliNIc acid]
60191000210109
2.0.0
18/11/2024
CRC Adjuvant - mDe Gramont [foliNIc acid and fluorouracil] [low dose foliNIc acid]
60181000210107
2.0.0
18/11/2024
CRC Adjuvant - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
52191000210104
2.0.0
18/11/2024
CRC Adjuvant - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
52201000210102
2.0.0
18/11/2024
CRC Adjuvant - mQUASAR [foliNIc acid and fluorouracil]
51901000210100
2.0.0
18/11/2024
CRC Adjuvant - mRoswell Park [foliNIc acid and fluorouracil] [high dose foliNIc acid]
52491000210109
2.0.0
18/11/2024
CRC Adjuvant - mRoswell Park [foliNIc acid and fluorouracil] [low dose foliNIc acid]
52621000210108
2.0.0
18/11/2024
CRC Neoadjuvant - nivolumab 3 mg/kg and ipilimumab 1 mg/kg
506811000210105
1.0.0
16/03/2026
CRC REC Locally advanced - capecitabine chemoradiation [5 day dosing]
52211000210100
3.0.0
07/02/2024
CRC REC Locally advanced - capecitabine chemoradiation [continuous dosing]
52221000210105
3.0.0
07/02/2024
CRC REC Locally advanced - dostarlimab
312021000210106
1.0.0
03/03/2024
CRC REC Locally advanced - fluorouracil chemoradiation
52231000210107
3.0.0
07/02/2024
CRC REC Neoadjuvant/Adjuvant - PRODIGE23 Total Neoadjuvant Therapy
components ▾
393551000210104
1.0.0
30/08/2024
FOLFIRINOX [oxaliplatin, irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid]
393561000210101
0.0.5
FOLFIRINOX [oxaliplatin, irinotecan, foliNIc acid and fluorouracil] [low dose foliNIc acid]
393571000210107
0.0.3
capecitabine chemoradiation
393581000210109
0.0.4
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
393591000210106
0.0.6
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
393601000210101
0.0.7
Adjuvant capecitabine
393611000210104
0.0.4
CRC REC Neoadjuvant - OPRA Total Neoadjuvant Therapy
components ▾
496871000210109
1.0.0
08/02/2025
capecitabine chemoradiation
496881000210106
0.0.3
fluorouracil chemoradiation
496891000210108
0.0.2
CAPOX [capecitabine and oxaliplatin]
496901000210109
0.0.2
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
496911000210106
0.0.1
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
496921000210101
0.0.2
CRC REC Neoadjuvant - PROSPECT Total Neoadjuvant Therapy
components ▾
496931000210104
1.0.0
08/02/2025
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
496941000210107
0.0.9
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
496951000210105
0.0.9
capecitabine chemoradiation [5 day dosing]
496961000210108
0.0.5
fluorouracil chemoradiation
496971000210102
0.0.3
CRC REC Neoadjuvant - RAPIDO Total Neoadjuvant Therapy
components ▾
311981000210103
1.0.0
03/03/2024
CAPOX [capecitabine and oxaliplatin]
311991000210101
0.0.5
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
312001000210103
0.0.1
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
312011000210101
0.0.1

Superseded Regimens

Name
Id
Version
Date
CRC Locally advanced - ipilimumab and nivolumab
311921000210104
1.0.2
29/03/2026

Rectal Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
CRC REC Locally advanced - capecitabine chemoradiation [5 day dosing]
52211000210100
3.0.0
07/02/2024
CRC REC Locally advanced - capecitabine chemoradiation [continuous dosing]
52221000210105
3.0.0
07/02/2024
CRC REC Locally advanced - dostarlimab
312021000210106
1.0.0
03/03/2024
CRC REC Locally advanced - fluorouracil chemoradiation
52231000210107
3.0.0
07/02/2024
CRC REC Metastatic - capecitabine chemoradiation [5 day dosing]
52631000210105
3.0.0
13/08/2023
CRC REC Metastatic - capecitabine chemoradiation [continuous dosing]
52791000210100
3.0.0
13/08/2023
CRC REC Metastatic - fluorouracil chemoradiation
52601000210100
3.0.0
13/08/2023
CRC REC Neoadjuvant/Adjuvant - PRODIGE23 Total Neoadjuvant Therapy
components ▾
393551000210104
1.0.0
30/08/2024
FOLFIRINOX [oxaliplatin, irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid]
393561000210101
0.0.5
FOLFIRINOX [oxaliplatin, irinotecan, foliNIc acid and fluorouracil] [low dose foliNIc acid]
393571000210107
0.0.3
capecitabine chemoradiation
393581000210109
0.0.4
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
393591000210106
0.0.6
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
393601000210101
0.0.7
Adjuvant capecitabine
393611000210104
0.0.4
CRC REC Neoadjuvant - OPRA Total Neoadjuvant Therapy
components ▾
496871000210109
1.0.0
08/02/2025
capecitabine chemoradiation
496881000210106
0.0.3
fluorouracil chemoradiation
496891000210108
0.0.2
CAPOX [capecitabine and oxaliplatin]
496901000210109
0.0.2
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
496911000210106
0.0.1
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
496921000210101
0.0.2
CRC REC Neoadjuvant - PROSPECT Total Neoadjuvant Therapy
components ▾
496931000210104
1.0.0
08/02/2025
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
496941000210107
0.0.9
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
496951000210105
0.0.9
capecitabine chemoradiation [5 day dosing]
496961000210108
0.0.5
fluorouracil chemoradiation
496971000210102
0.0.3
CRC REC Neoadjuvant - RAPIDO Total Neoadjuvant Therapy
components ▾
311981000210103
1.0.0
03/03/2024
CAPOX [capecitabine and oxaliplatin]
311991000210101
0.0.5
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
312001000210103
0.0.1
mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]
312011000210101
0.0.1